| Literature DB >> 30563492 |
Harmeet Kaur1,2, Neetu Sain3, Debasisa Mohanty3, Dinakar M Salunke4,5.
Abstract
BACKGROUND: Antibody, the primary effector molecule of the immune system, evolves after initial encounter with the antigen from a precursor form to a mature one to effectively deal with the antigen. Antibodies of a lineage diverge through antigen-directed isolated pathways of maturation to exhibit distinct recognition potential. In the context of evolution in immune recognition, diversity of antigen cannot be ignored. While there are reports on antibody lineage, structural perspective with respect to diverse recognition potential in a lineage has never been studied. Hence, it is crucial to evaluate how maturation leads to topological tailoring within a lineage enabling them to interact with significantly distinct antigens.Entities:
Keywords: Antibody; Antigens; Cluster; Conformation; Data science; Germline; Mature; Paratope; Simulation; Somatic hypermutation
Mesh:
Substances:
Year: 2018 PMID: 30563492 PMCID: PMC6299584 DOI: 10.1186/s12900-018-0096-1
Source DB: PubMed Journal: BMC Struct Biol ISSN: 1472-6807
Fig. 1Data collation. Compiled dataset of Ab-Ag complexes from (a) mouse and (b) human, retrieved from PDB. Antibodies sharing common germline V gene (shown along Y-axis) were clustered together and the number of complexes is plotted along X-axis with their PDB IDs. Percentage of chemically distinct antigens bound by mature antibodies is represented in the pie chart
Fig. 2Variability in CDR loops of antibodies. RMSD plots of CDR loops of heavy and light chains of antibodies from (a) mouse and (b) human
Ab-Ag complexes as test systems for study
| Organism | PDB ID | Antibody | Antigen | Score (Bits) | e-value | |
|---|---|---|---|---|---|---|
| Mouse | 2OK0 | ED10 | DNA |
| 171 | 2e-44 |
| 3BT2 | Anti-uPAR | Urokinase plasminogen activator surface receptor, Vitronectin |
| 162 | 1e-41 | |
| 1YJD | 5.11A1 | T-cell-specific surface glycoprotein CD28 |
| 140 | 5e-35 | |
| Human | 4NRX | m66 | Gp41 MPER peptide |
| 219 | 5e-59 |
| 4HWB | 10G5H6 | Ectodomain D3 of IL-13 |
| 237 | 3e-64 | |
| 3UJI | 2558 | Gp160 V3-domain |
| 204 | 2e-54 | |
| 4HPO | CH58 | Gp120 V2-domain |
| 243 | 5e-66 |
Fig. 3Mapping somatic mutations on sequences and structures of antibodies of V1–84 lineage. a Multiple sequence alignment of the variable region of heavy chain of mature antibodies with the germline sequence. Mutations in the CDRs and FW regions are highlighted in red. b Frequency of V mutations and percent identity with corresponding germline sequence. c Stereo view of ribbon representation of structure superposition of free antibodies (last structure of simulation) showing the mutated residues of V region in sticks. Stereo view of ribbon representation of structure superposition of respective free antibodies (last structure of simulation) and bound forms (crystal structures) of (d) Fab ED10 (PDB ID: 2OK0), (e) Fab 5.11A1 (PDB ID: 1YJD) and (f) anti-uPAR (PDB ID: 3BT2) antibody
Somatic mutation and interacting residues in antibodies of V5–51 and V1–84 lineages
| Germline lineage | PDB ID | Interacting residues on H-chain | |
|---|---|---|---|
|
| 4NRX | Q1, V24, A30, E32, K58, I68, N76, I89 | S31, W33, D54, D56, Y100C, R100F, T100G |
| 4HWB | V51, Y58 | S32, D56, S57, R60, N102, W34 | |
|
| 2OK0 | V2, E5, E6, M33, L36, R37, K39, V51, I56, D65, A71, I77, V78, H81, D85, N87,T92 | N35, G98 |
| 1YJD | V2, T16, R19, E23, S31, H35, C50, N55,V56, N59, D65, I71, R85, M86, T97 | S31,Y101, G102, D104 | |
| 3BT2 | V2, K3, V11, S28,N31, F32, H35, F52, H52A, D55, E58, D65, A70, | Y33, W50, D55, N56, T57, E58 |
Fig. 4Mapping somatic mutations on sequences and structures of antibodies of V 5–51 lineage. a Multiple sequence alignment of the variable region of heavy chain of mature antibodies with the germline sequence. Mutations in the CDRs and FW regions are highlighted in red. b Frequency of V mutations and percent identity with corresponding germline sequence. c Stereo view of ribbon representation of structure superposition of free antibodies (last structure of simulation) showing the mutated residues of V region in sticks. Stereo view of ribbon representation of structure superposition of respective free antibodies (last structure of simulation) and bound forms (crystal structures) of (d) Fab 10G5H6 (PDB ID: 4HWB) and (e) Fab m66 (PDB ID: 4NRX)
Fig. 5Conformational clusters of V1–84 lineage. Sampled conformations were clustered (color coded) and represented in an RMSD versus time plot for respective free and bound (a) 5.11A1, (b) ED10 and (c) anti-uPAR antibodies, across 0.5 μs trajectory. Least RMSD representative antibody of each cluster is shown. Same color code between respective bound and free forms reflects the same cluster. Graphs in the lower panel show percent population of free and bound antibodies in each cluster
Fig. 6Conformational clusters of V5–51 lineage. Sampled conformations were clustered (color coded) and represented in an RMSD versus time plot for respective free and bound (a) 10G5H6, (b) m66 antibodies across 0.5 μs trajectory. Least RMSD representative antibody of each cluster is shown. Same color code between respective bound and free forms reflects the same cluster. Graphs in the lower panel show percent population of free and bound antibodies in each cluster
Fig. 7Rigidity in paratope of mature antibodies. Stereo view of ribbon representation of structure superposition of conformers from individual clusters of bound (upper panel) and free (lower panel) antibodies (a) anti-uPAR (red), 5.11A1 (blue) and ED10 (green) of V1–84 lineage (on the left), and (b) 10G5H6 (blue) and m66 (red) of V5–51 lineage (on the right)
Fig. 8Binding energy of antibodies for respective antigens. ΔG values obtained from MM-GB/SA analysis have been plotted across the trajectories of (a) 5.11A1 (blue), anti-uPAR (red) and ED10 (green) from V1–84 lineage and (b) m66 (blue) and 10G5H6 (red) from V5–51 lineage